Biotechnology Stocks I Performance Guide: Compare Returns of S&P 500 and Intellia Therapeutics, Inc. (NTLA)
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
Compare Returns for S&P 500 and NTLA | ||
---|---|---|
S&P 500 | NTLA | |
Start Date | Jun-01-2016 | Jun-30-2016 |
Start Price | $2,476.46 | $21.35 |
End Date | May-01-2024 | May-17-2024 |
End Price | $5,018.39 | $26.22 |
Number Monthly Prices | 96 | 96 |
Min Date | Jun-01-2016 | May-31-2017 |
Min Price | $2,695.52 | $11.46 |
Max Date | Apr-01-2024 | Jun-30-2021 |
Max Price | $5,243.77 | $161.91 |
Total Return | 86.18% | 22.81% |
Annualized Return | 8.08% | 2.60% |
Current Value of $1,000 Purchase | $1,862 | $1,228 |
Number Returns | 4,560 | 4,560 |
Average Return | 23.03% | 129.65% |
Minimum Return | -25.54% | -86.78% |
Maximum Return | 94.54% | 1,312.83% |
Number Profitable Returns | 3,957 | 3,050 |
Percent Profitable Returns | 86.78% | 66.89% |
Number Unprofitable Returns | 603 | 1,510 |
Percent Unprofitable Returns | 13.22% | 33.11% |
Profitable to Unprofitable Returns Ratio | 6.56 | 2.02 |
NTLA Performance Table and Chart
NTLA Dollar-cost Average
NTLA Trendline Chart
NTLA Moving Average Chart
NTLA Stock Return Map - See Patterns of Gains and Losses
NTLA Stock Returns/Purchase Dates